Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor
H van Cruijsen, K Hoekman, A G M Stam, A J M van den Eertwegh, B C Kuenen, R J Scheper, G Giaccone, T D de Gruijl
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor'. Together they form a unique fingerprint.